| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |